Related Experiment Video
Updated: May 5, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase
Angela Corona1, Takashi Masaoka, Graziella Tocco
1Department of Life & Environmental Sciences - Unit of Biomedicine, University of Cagliari, Italy.
Abstract:
Despite the wealth of information available for the reverse transcriptase (RT)-associated ribonuclease H (RNaseH) domain of lentiviruses, gammaretroviruses and long terminal repeat containing retrotransposons, exploiting this information in the form of an RNaseH inhibitor with high specificity and low cellular toxicity has been disappointing. However, it is now becoming increasingly evident that the two-subunit HIV-1 RT is a highly versatile enzyme, undergoing major structural alterations in order to interact with, position and ultimately hydrolyze the RNA component of an RNA/DNA hybrid. Thus, in addition to targeting the RNaseH active site, identifying small molecules that bind elsewhere and disrupt catalysis allosterically by impairing conformational flexibility is gaining increased attention. This review summarizes current progress towards development of both active site and allosteric RNaseH inhibitors.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Enzyme Inhibition
Ribozymes
Ribozymes can...
Ribozymes
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Retrovirus Life Cycles

